Vaginal Smears

• 

  Subject Areas on Research

  • A Pilot Study of a Screening Program for Human Papillomavirus-Related Squamous Intraepithelial Lesion and Malignancy in Gynecologic Oncology Patients. 
  • A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. 
  • A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. 
  • A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women. 
  • A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening. 
  • Abnormal outcomes following cervical cancer screening: event duration and health utility loss. 
  • Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • An abnormal cervicovaginal cytology smear in uterine carcinosarcoma is an adverse prognostic sign: analysis of 25 cases. 
  • Associations between obesity and receipt of screening mammography, Papanicolaou tests, and influenza vaccination: results from the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) Study. 
  • Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials. 
  • Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. 
  • Cancer screening before and after switching to a high-deductible health plan. 
  • Cancer screening behaviors and attitudes of women in southeastern Minnesota. 
  • Cancer screening in the elderly. 
  • Cancer screening practices among women in a community health center population. 
  • Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. 
  • Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. 
  • Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. 
  • Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. 
  • Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. 
  • Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. 
  • Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. 
  • Costs of integrating cervical cancer screening at an HIV clinic in Kenya. 
  • Cytologic features of adenocarcinoma, not otherwise specified, in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytologic features of squamous cell carcinoma in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytologic screening after hysterectomy for benign disease. 
  • Cytological evaluation correlates poorly with histological diagnosis of vulvar neoplasias. 
  • Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. 
  • De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. 
  • Do proficiency test results correlate with the work performance of screeners who screen Papanicolaou smears? 
  • Effectiveness of health maintenance reminders provided directly to patients. 
  • Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipients. 
  • Emergency department pelvic examination and Pap testing: addressing patient misperceptions. 
  • Eubacterium nodatum mimics Actinomyces in intrauterine device-associated infections and other settings within the female genital tract. 
  • Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study. 
  • Evaluating a stage model in predicting monolingual spanish-speaking Latinas' cervical cancer screening practices: the role of psychosocial and cultural predictors. 
  • Evaluation of cervical cytology. 
  • Factors affecting compliance with clinical practice guidelines for pap smear screening among healthcare providers in africa: systematic review and meta-summary of 2045 individuals. 
  • Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. 
  • HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. 
  • Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey. 
  • How Providing Cervical Cancer Screening Results via Cell Phone Affects Patient Follow-Up Rates in Western Kenya. 
  • Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. 
  • Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. 
  • Impact of Patient Navigation Interventions on Timely Diagnostic Follow Up for Abnormal Cervical Screening. 
  • Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. 
  • Improving the sensitivity of cervical cytology: what are the issues? 
  • Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. 
  • Increased Rate of ASCUS Diagnosis With Concomitant Request for High-Risk Human Papillomavirus Reflex Testing May Be Due to Cognitive Bias. 
  • Incremental and average cost-effectiveness ratios: will physicians make a distinction? 
  • Knowledge about human papillomavirus among adolescents. 
  • Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? 
  • Measuring the significance of participant evaluation of acceptability of cases in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5. 
  • Pain predicts non-adherence to pap smear screening among middle-aged African American women. 
  • Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study. 
  • Pediatricians are more supportive of the human papillomavirus vaccine than the general public. 
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. 
  • Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. 
  • Prevalence and severity of cervical squamous intraepithelial lesion in a tertiary hospital in northern Tanzania. 
  • Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus. 
  • Primary adenocarcinoma of the gallbladder presenting as primary gynecologic malignancy: a report of two cases. 
  • Prospective correlation of cervicovaginal cytologic and histologic specimens. 
  • Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. 
  • Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening. 
  • Reproducibility of self-reported pap test utilization in middle-aged African-American women. 
  • Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. 
  • Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). 
  • Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. 
  • Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. 
  • Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol. 
  • Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya. 
  • Technologic advances for evaluation of cervical cytology: is newer better? 
  • The effect of comorbid illness on receipt of cancer screening by older people. 
  • The impact of health status on physicians' intentions to offer cancer screening to older women. 
  • The impact of tailored interventions on a community health center population. 
  • The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • Towards a field-compatible optical spectroscopic device for cervical cancer screening in resource-limited settings: effects of calibration and pressure. 
  • US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. 
  • Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. 
  • Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine